The accurate early detection and precise localization of diseases remain pivotal challenges in modern medicine. Traditional diagnostic methods often grapple ...

ROCKVILLE, Md. – May 27, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the release of a three-part series of scientific ...

Polymerase Chain Reaction Market To Reach US$31.3Bn By 2033 Persistence Market Research. EINPresswire/ -- The global polymerase chain reaction (PCR) market, integral to molecular diagnostics and life ...

Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as a diagnostic marker, a key ...

Next-generation sequencing (NGS) platforms, along with immunotherapies like checkpoint inhibitors, have brought the promise of precision medicine for cancer patients closer to reality. Terence Rhodes, ...

Delray Beach, FL, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Investments in precision medicine, expanding healthcare infrastructure, and rising infectious disease burden fuel market growth The global molecular ...

QuidelOrtho Corporation (NASDAQ:QDEL) has announced a strategic pivot in its molecular diagnostics business, seeking to acquire full ownership of LEX Diagnostics following projected 510(k) FDA ...

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key ...

GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...